Homozygosity for the -1639 G>A single nucleotide functional promoter polymorphism of the VKORC1 gene ( genotype AA ; 14 5 % of cases ) was associated with a significantly shortened time to therapeutic INR > = 2 ( P < 0 01 ) , reduced stable warfarin dose ( P < 0 01 ) , and an increased number of INRs > 5 ( P < 0 001 ) and occurrence of bleeding events ( P < 0 01 ) during the first month , as compared to the GG genotype .